Mitochondrial gene expression, copy number, and biogenesis were also all increased in our PD cybrid cell line after the expression of Ndi1, suggesting that Ndi1 warrants further investigation as a source of insight into potential therapies for PD and other mitochondrial diseases. Here, AVPR2 is linked to inborn mitochondrial metabolism disorder.